ACEI-001A

ACEI-001A
Product Description

Cpc provides wide range of products which includes acei-001a. Category: ace inhibitors. Contact us for more information.

CPC Scientific.Inc

  • US
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
CMO/CDMO
Specifications
  • Details
    Molecular formula:C53H76N14O12. molecular Weight:1101.3
  • Selling Points
    Experienced Technicians; Prompt Delivery; Quality Service
  • Supplied from
    United States

CPC Scientific.Inc

  • US
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
CMO/CDMO

More Products from CPC Scientific.Inc (99)

  • (Des-octanoyl)-Ghrelin, human 1mg

    Product (Des-octanoyl)-Ghrelin, human 1mg

    Chinese peptide co provides wide range of products which includes (des-octanoyl)-ghrelin, human 1mg. It belongs toghrelins category. Contact us for more information.
  • (Glp1)-Apelin-13, human, bovine 0.5mg

    Product (Glp1)-Apelin-13, human, bovine 0.5mg

    Chinese peptide co provides wide range of products which includes (glp1)-apelin-13, human, bovine 0.5mg. It belongs toapelin peptides category. Contact us for more information.
  • Generic Peptides

    Product Generic Peptides

    GMP-grade peptide APIs AVAILABLE GENERIC PEPTIDES: • Bivalirudin trifluoroacetate • Eptifibatide acetate • Exenatide acetate • Glatiramer acetate • Glucagon acetate • Glucagon hydrochloride • Glucagon-like peptide • Gonadorelin acetate • Goserelin acetate • Leuprolide acet...
  • GMP Peptide Manufacturing

    Product GMP Peptide Manufacturing

    With more than a decade of committed service to the peptide industry, CPC Scientific is a trusted provider of high-quality peptides to researchers and pharmaceutical companies all over the world. The CPC Group is comprised of peptide experts who have actively pursued peptide design and large scale ...
  • Catalog Peptides

    Product Catalog Peptides

    CPC Scientific provides high-quality, ready-to-use peptides to make your life easier by increasing your efficiency and reducing your costs. Each month, we unveil our latest peptides designed for your most urgent research needs. Many of these peptides have been frequently cited in the lite rature...
  • ACAS-002A

    Product ACAS-002A

    Cpc provides wide range of products which includes acas-002a. Category: alpha-casein exorphins. Contact us for more information.
  • ACEI-003A

    Product ACEI-003A

    Cpc provides wide range of products which includes acei-003a. Category: ace inhibitors. Contact us for more information.
  • ACEI-004A

    Product ACEI-004A

    Cpc provides wide range of products which includes acei-004a. Category: ace inhibitors. Contact us for more information.
  • ACET-001A

    Product ACET-001A

    Cpc provides wide range of products which includes acet-001a. Category: acetalin. Contact us for more information.
  • ACET-002A

    Product ACET-002A

    Cpc provides wide range of products which includes acet-002a. Category: acetalin. Contact us for more information.
  • ACEI-002A

    Product ACEI-002A

    Cpc provides wide range of products which includes acei-002a. Category: ace inhibitors. Contact us for more information.
  • ACET-003A

    Product ACET-003A

    Cpc provides wide range of products which includes acet-003a. Category: acetalin. Contact us for more information.

CPC Scientific.Inc resources (1)

  • News Terlipressin Formulation with API Manufactured by CPC Scientific Approved for Further Study by the MEB

    SAN JOSE, CA., Feb 1, 2021 /CPCNewswire/ — CPC Scientific Inc. is pleased to announce that the Dutch Medicines Evaluation Board (MEB) has completed its technical review of their client’s drug product and formulation process for Terlipressin. The API provided to the client is manufactured at CPC Scientific’s GMP facility. On January 18, 2021, the MEB granted approval of the drug product and will move to the next phase to review product characterization profiles, specifications, and labels in the Netherlands. The MEB is the Dutch regulatory agency responsible for assessing, monitoring, and promoting the proper use of medicines. After final approval, the drug product will be available for sale in the Netherlands and Germany.